Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04TUG
|
|||
| Drug Name |
Heteroaromatic ring derivative 3
|
|||
| Synonyms |
PMID28447479-Compound-18
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NOVARTIS AG BEATTIE, David BAETTIG, Urs LEGRAND, Darren Mark LISTER, Andrew Stuart MCKENNA, Jeffrey PEARCE, David William SANDHAM, David Andrew STEWARD, Oliver Ross THOMSON, Christopher
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
| KEGG Pathway | Ether lipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.